Collectively, these findings indicated that in HCC cells treated with platinum drugs, targeted inhibition of mito-COX-2 enhanced the chemosensitivity by suppressing the mito-COX-2/p-Drp1Ser616 interaction mediating mitochondrial fission. This evidence concerns the gene PTGS2 and hepatocellular carcinoma.